Company news
Medicure Inc. news in 2018
Medicure Inc.'s news releases, calls and decks from 2018, newest first.
Medicure reports financial results for quarter ended September 30, 2018
November 20, 2018
Medicure Q3 2018 Results and Conference Call Dates
November 14, 2018
Medicure Reports Financial Results for Quarter Ended June 30, 2018
August 15, 2018
Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection
August 13, 2018
Medicure Q2 2018 Results and Conference Call Dates
August 8, 2018
Medicure Reports Financial Results for Quarter Ended March 31, 2018
May 23, 2018
Medicure Q1 2018 Results and Conference Call Dates
May 17, 2018
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2017
May 1, 2018
Medicure announces availability of ZYPITAMAG(TM) (pitavastatin) in the U.S.
May 1, 2018
Medicure to Announce Fiscal Year End 2017 Financial Results on April 30, 2018
April 24, 2018
Medicure Announces Further Up-Date on PREXXARTAN®
March 28, 2018
Medicure Announces an Up-Date on PREXXARTAN® Launch
March 19, 2018
Zydus partners with Medicure to launch its NDA Product, ZYPITAMAG (pitavastatin) in the U.S.
March 7, 2018
Medicure Announces Receipt of Deferred Proceeds from Apicore Sale
February 1, 2018